Clinical Trials List
2023-03-01 - 2027-12-31
Others
Not yet recruiting3
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ming-Huang Chen Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Chien-An Liu Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Po-Wen Lin Division of General Surgery
- 黃盈慈 Division of Hematology & Oncology
- 陳柏全 Division of General Surgery
- Shang-Hung Chen Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
340 participants
